Not actual patients. Text does not represent an actual patient quote.
If you have an inherited retinal disease (IRD) due to mutations in both copies of your RPE65 gene and enough remaining cells in your retina, LUXTURNA may help brighten up the night. LUXTURNA is a one-time gene therapy recommended for patients 12 months of age and older.
Shed light on your IRD. Ask your healthcare provider for a genetic test to determine if LUXTURNA is right for you.
A LUXTURNA Journey
Follow Monroe's treatment journey to see how LUXTURNA gave her a 2nd chance at life's firsts.
WATCH NOW

Actual patient.


Not an actual patient.
Patient Support
Get to know Spark Therapeutics Generation Patient ServicesSM, our support program for eligible* patients
Find out more